TECH - Bio-Techne Corp -  [ ]

Ticker Details
Bio-Techne Corp
Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products.
IPO Date: March 1, 1989
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $9B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.47 | 1.16%
Avg Daily Range (30 D): $1.21 | 1.88%
Avg Daily Range (90 D): $1.03 | 1.67%
Institutional Daily Volume
Avg Daily Volume: 1.56M
Avg Daily Volume (30 D): 2.18M
Avg Daily Volume (90 D): 1.71M
Trade Size
Avg Trade Size (Sh.): 314
Avg Trade Size (Sh.) (30 D): 57
Avg Trade Size (Sh.) (90 D): 53
Institutional Trades
Total Institutional Trades: 7,791
Avg Institutional Trade: $4.86M
Avg Institutional Trade (30 D): $5.56M
Avg Institutional Trade (90 D): $5.22M
Avg Institutional Trade Volume: .28M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $8.91M
Avg Closing Trade (30 D): $23.49M
Avg Closing Trade (90 D): $18.67M
Avg Closing Volume: 401.02K
 
News
Feb 4, 2026 @ 11:30 AM
Bio-Techne Declares Dividend
Source: Prnewswire
Jan 21, 2026 @ 9:42 AM
Middle East Exosomes Market Research Report 2025-2...
Source: Researchandmarkets.Com
Nov 5, 2025 @ 11:30 AM
BIO-TECHNE DECLARES DIVIDEND
Source: Prnewswire
Sep 15, 2025 @ 9:29 PM
Mdxhealth Announces Closing of Exosome Diagnostics...
Source: Globe Newswire
Sep 3, 2025 @ 6:45 PM
Bio-Techne Stock Upgraded As Analyst Flags Attract...
Source: Vandana Singh
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $.52 $.24 $.25
Diluted EPS $.51 $.24 $.24
Revenue $1.22B $295.88M $286.56M
Gross Profit $792.76M $191.28M $188.11M
Net Income / Loss $81.1M $38.01M $38.19M
Operating Income / Loss $116.97M $54.46M $47.66M
Cost of Revenue $422.82M $104.6M $98.44M
Net Cash Flow $-16.15M $27.5M $-16.01M
PE Ratio 112.94    
Splits
Nov 30, 2022 4:1
Nov 10, 2022 4:1
Dec 04, 2000 2:1